宾得医疗将 C2 CryoBalloon 资产出售给 Merit Medical，用于心脏消融扩张。 Pentax Medical sells C2 CryoBalloon assets to Merit Medical for cardiac ablation expansion.

PENTAX Medical同意将C2 CryoBalloon产品系列出售给特效医疗系统,进行资产购买交易,标志着心脏消融装置市场的转变。 PENTAX Medical has agreed to sell its C2 CryoBalloon product line to Merit Medical Systems in an asset purchase deal, marking a shift in the cardiac ablation device market. 该交易包括所有相关资产、知识产权和制造权。 The transaction includes all related assets, intellectual property, and manufacturing rights. 梅里特医疗公司的目标是扩大其在微创心脏病治疗领域的产品组合. Merit Medical aims to expand its portfolio in minimally invasive cardiology treatments. 预计销售将结束,等待监管批准和习惯性关闭条件。 The sale is expected to close pending regulatory approvals and customary closing conditions.